News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Staff Weighs Auxilium Pharmaceuticals Hand Disorder Drug; Xiaflex Effective, Side Effects Minor
September 15, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Shares of Auxilium Pharmaceuticals Inc rose more than 20 percent on Monday after U.S. health regulators in a memo said its experimental drug to treat a potentially crippling hand disorder offers relief with mostly minor side effects.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Lung cancer
Summit’s Keytruda Challenger Hits Cross-Country Consistency Problems, Raising US Approval Questions
September 8, 2025
·
2 min read
·
Tristan Manalac
GLP-1
WHO Adds GLP-1s to List of Essential Medicines
September 8, 2025
·
2 min read
·
Tristan Manalac
Government
Monarez Blasts Partisan Public Health Policy at CDC Under RFK Jr.
September 5, 2025
·
2 min read
·
Tristan Manalac
HIV
Gilead Partners With US State Department to Distribute Yeztugo to Low-Income Countries
September 5, 2025
·
1 min read
·
Tristan Manalac